Trial Projects

What is a Trial Project?
1 Trial Project found

The prognosis of patients with newly diagnosed glioblastoma is dismal despite recent therapeutic improvements Using standard therapy with temozolomide (TMZ) and radiotherapy (60 Gy), the median overall survival time (mOS) is 14.6 months (Stupp et al., 2005). Since in a previous non-randomized bicentric phase II trial, primary combination chemotherapy with lomustine (CCNU) and TMZ was highly effective (mOS 23 months; UKT-03 trial; Herrlinger et al., 2006; Glas et al., 2009) the proposed trial ...

Public web page: https://clinicaltrials.gov/study/NCT01149109

Start date: 1st Oct 2010

End date: 6th Apr 2017

Powered by
(v.1.15.2)
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH